Camp4 Therapeutics (CAMP) Capital Leases (2023 - 2025)

Camp4 Therapeutics has disclosed Capital Leases across 3 years of filings, most recently posting $47000.0 for Q3 2025.

• Capital Leases for Q3 2025 came in at $47000.0, down 45.98% year-over-year; the trailing twelve-month figure through Sep 2025 was $47000.0 (down 45.98% YoY), and the FY2024 annual result was $70000.0, down 52.7% from the prior year.
• Capital Leases came in at $47000.0 for Q3 2025 at Camp4 Therapeutics, down from $59000.0 in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $148000.0 in Q4 2023 to a low of $47000.0 in Q3 2025.
• The 3-year median for Capital Leases is $64500.0 (2024), against an average of $78166.7.
• Across the five-year window, Capital Leases sank 52.7% in 2024 and tumbled 45.98% in 2025, its largest moves.
• Camp4 Therapeutics' Capital Leases stood at $148000.0 in 2023, then tumbled by 52.7% to $70000.0 in 2024, then plunged by 32.86% to $47000.0 in 2025.
• The last three Capital Leases figures came in at $47000.0 (Q3 2025), $59000.0 (Q2 2025), and $58000.0 (Q1 2025), per Business Quant data.